SaMD Diabetes Software Experts
Both NFC and BLE are wireless communication technologies commonly used in connected medical devices. Each has different technical specifications and use cases. Understanding these can help you determine which is better suited to the needs of your medical device.
Three over-the-counter CGM devices are expected to hit the market in 2024. Find out what each of these products offers and how these connected device companies managed to attain OTC designation for products that have historically been prescription only.
Understanding whether your mobile medical app falls under FDA regulation is key to determining your pathway to market. Here, we offer a five-step decision tree to help you decide where your app falls regarding FDA regulation.
The next generation of wireless technology promises many benefits for connected devices. But MedTech companies must know how to navigate the challenges of this network before integrating 5G into their connected device solutions.
Both dedicated teams and staff augmentation can be beneficial for MedTech companies who lack the software expertise in-house to complete their medical device project. But each comes with different pros and cons that MedTech companies need to be aware of before they decide which is best for them.
Advancements in biosensors offer many opportunities for innovative MedTech companies to develop more effective diabetes monitoring devices, but only if these companies can overcome the many challenges standing in the way of these products reaching the market.
SaMD Diabetes Software Experts
Copyright © 2023 Sequenex